摘要
目的观察针刺分离术联合滤过泡旁注射α2b干扰素治疗小梁切除术后包裹性囊状滤过泡的疗效。方法对12名小梁切除术后并发包裹性囊状滤过泡的患者行针刺分离术,术后滤过泡旁注射α2b干扰素。随访观察眼压和滤过泡形态。结果治疗前平均眼压为(27.67±2.96)mmHg,治疗后为(15.25±3.02)mmHg,治疗前后眼压比较,差异有显著意义。治疗后Ⅰ型滤过泡3眼,Ⅱ型滤过泡8眼,Ⅲ型滤过泡1眼。结论针刺分离术联合干扰素可以治疗早期治疗失败的滤过泡,增加滤过手术的成功率,值得临床上推广应用。
Objective To observe the curative effect of acupuncture separation combined with injection of recombinant human interferon α2b(rhIFN α2b) around bulbar conjunctiva on encapsulated filtering bled after trabeculectomy. Methods Twelve patients with encapsulated filtering bled after trabeculectomy were subjected to acupuncture separation,then injected with rhIFN α2b around bulbar conjunctiva and followed-up for intraocular pressure(IOP) and the form of filtering bled. Results The mean IOPs before and after treatment were (27.67 ± 2. 96) mmHg and ( 15.25 ±3.02 ) mmHg respectively, which showed significant difference. The filter bled type Ⅰ , Ⅱ and Ⅲ were observed in 3,8 and 1 eyes respectively, Conclusion Acupuncture separation combined with injection of rhIFN α2b around bulbar conjunctiva showed good curative effect on encapsulated filtering bled at early stage and increased the success rate of filtering surgery. It was value of popularization in clinic.
出处
《中国生物制品学杂志》
CAS
CSCD
2007年第6期457-458,共2页
Chinese Journal of Biologicals
关键词
针刺分离术
滤过泡
重组人干扰素
青光眼
Acupuncture separation
Filtering bled
Recombinant human interferon
Glaucoma